STAT

The FDA wants to cut cigarettes’ nicotine levels. Will that help people quit?

What would be the impact on cigarette smokers of reducing the amount of tobacco in cigarettes? Some research points toward an answer.
Source: Joel Saget/AFP/Getty Images

For the first time in history, the Food and Drug Administration plans to regulate the level of nicotine in cigarettes, attempting to bring it down to “non-addictive” levels. The move, announced Friday, was praised by scientists — who also noted that there’s no consensus on what a “non-addictive” level of nicotine is.

“I guess I personally would frame it as less addictive, because I’m not sure about that, ‘non-addictive,’” said Eric Donny, director of the that he wanted to reduce the nicotine level in cigarettes until they were “minimally or non-addictive.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks